BY4 (Primaquine Phosphate 15mg (base))
Pill with imprint BY4 is Purple, Round and has been identified as Primaquine Phosphate 15mg (base). It is supplied by Bayshore Pharmaceuticals, LLC.
Primaquine is used in the treatment of pneumocystis pneumonia; malaria; malaria prevention and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 15mg (base) is not a controlled substance under the Controlled Substances Act (CSA).
Images for BY4

Primaquine Phosphate
- Imprint
- BY4
- Strength
- 15mg (base)
- Color
- Purple
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antimalarial quinolines
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bayshore Pharmaceuticals, LLC
- National Drug Code (NDC)
- 60429-0035
- Inactive Ingredients
-
microcrystalline cellulose,
corn starch,
lactose monohydrate,
magnesium stearate,
water,
titanium dioxide,
FD&C Red No. 40,
FD&C Blue No. 2
Note: Inactive ingredients may vary.
Related images for "BY4"
More about primaquine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (1)
- Drug images
- Pricing & coupons
- En español
- Drug class: antimalarial quinolines
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.